Data for action: collection and use of local data to end tuberculosis

G Theron, HE Jenkins, F Cobelens, I Abubakar… - The Lancet, 2015 - thelancet.com
Accelerating progress in the fight against tuberculosis will require a drastic shift from a
strategy focused on control to one focused on elimination. Successful disease elimination …

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

MX Rangaka, RJ Wilkinson, A Boulle, JR Glynn… - The Lancet, 2014 - thelancet.com
Background Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more
common in people with HIV than in people without HIV. We aimed to assess the effect of …

Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings?

DW Dowdy, MA Behr - The Lancet Infectious Diseases, 2022 - thelancet.com
The annual risk of infection with Mycobacterium tuberculosis determines a population's
exposure level and thus the fraction of incident tuberculosis resulting from recent infection …